14401-60-6

Basic information

• Product Name: 2-BROMO-5-METHYL-4-NITROPHENOL
• Synonyms: 2-BROMO-5-METHYL-4-NITROPHENOL
• CAS NO: 14401-60-6
• Molecular Formula: C₇H₆BrNO₃
• Molecular Weight: 232.03
• Mol File: 14401-60-6.mol

Chemical Properties

• Melting Point: 127 °C
• Boiling Point: 310.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.755±0.06 g/cm3(Predicted)
• PKA: 5.63±0.24(Predicted)
• CAS DataBase Reference: 2-BROMO-5-METHYL-4-NITROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-5-METHYL-4-NITROPHENOL(14401-60-6)
• EPA Substance Registry System: 2-BROMO-5-METHYL-4-NITROPHENOL(14401-60-6)

Safety Data

• Hazardous Substances Data: 14401-60-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-BROMO-5-METHYL-4-NITROPHENOL is used as an intermediate in the synthesis of various pharmaceuticals for its anti-bacterial and anti-fungal properties, contributing to the development of effective treatments against infections.
Used in Agrochemical Industry:
In the agrochemical industry, 2-BROMO-5-METHYL-4-NITROPHENOL is used as a key component in the production of fungicides, helping to protect crops from fungal infections and ensuring a stable food supply.
Used in Organic Synthesis:
2-BROMO-5-METHYL-4-NITROPHENOL is used as a reagent in organic synthesis, enabling the creation of a wide range of organic compounds for various applications, including the development of new materials and pharmaceuticals.
Used in Dye Industry:
As a dye intermediate, 2-BROMO-5-METHYL-4-NITROPHENOL is utilized in the production of dyes, contributing to the vibrant colors and hues found in textiles, plastics, and other materials.
It is crucial to handle 2-BROMO-5-METHYL-4-NITROPHENOL with care due to its toxic and harmful properties, ensuring the safety of both individuals and the environment.

Upstream product

• 2581-34-2 3-methyl-4-nitrophenol 
• 224185-19-7 3-bromo-4-fluoro-6-methylnitrobenzene 

Downstream Products

• 861084-04-0 5-bromo-4-methoxy-2-methylbenzenamine 
• 5456-94-0 2,4-dibromo-5-methylanisole 
• 861076-28-0 1-bromo-2-methoxy-4-methyl-5-nitrobenzene 

Relevant articles and documents

QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS

The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

AMINOPYRAZOLE DERIVATIVES

An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.

Glucokinase Activators

Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders.

INDOLES AS 5-HT6 MODULATORS

The present invention relates to novel compounds of formula (I) wherein m, n, R0, R1, R2, R3 and R4 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for t